4.7 Article

Novel Thiol Containing Hybrid Antioxidant-Nitric Oxide Donor Small Molecules for Treatment of Glaucoma

期刊

ANTIOXIDANTS
卷 10, 期 4, 页码 -

出版社

MDPI
DOI: 10.3390/antiox10040575

关键词

nitric oxide; superoxide radical; hybrid small molecule; glaucoma; intra-ocular pressure; nanosuspension

资金

  1. Applied Research Seed grant from UNTHSC [2400018]
  2. Bright Focus Foundation [G2018056]
  3. National Institute of Health [R01EY029823]

向作者/读者索取更多资源

Oxidative stress-induced death and dysregulation of trabecular meshwork (TM) cells contribute to increased intraocular pressure (IOP) in primary open angle (POAG) glaucoma, while nitric oxide (NO) can lower IOP by reducing reactive oxygen species (ROS). The novel sulfur containing hybrid NO donor-antioxidants were designed to scavenge ROS and maintain NO bioavailability in TM cells, demonstrating potential for glaucoma treatment. The slow-release nanosuspension of these molecules significantly lowered IOP in a mouse model, showing lasting effects up to 72 hours.
Oxidative stress induced death and dysregulation of trabecular meshwork (TM) cells contribute to the increased intraocular pressure (IOP) in primary open angle (POAG) glaucoma patients. POAG is one of the major causes of irreversible vision loss worldwide. Nitric oxide (NO), a small gas molecule, has demonstrated IOP lowering activity in glaucoma by increasing aqueous humor outflow and relaxing TM. Glaucomatous pathology is associated with decreased antioxidant enzyme levels in ocular tissues causing increased reactive oxygen species (ROS) production that reduce the bioavailability of NO. Here, we designed, synthesized, and conducted in vitro studies of novel second-generation sulfur containing hybrid NO donor-antioxidants SA-9 and its active metabolite SA-10 to scavenge broad-spectrum ROS as well as provide efficient protection from t-butyl hydrogen peroxide (TBHP) induced oxidative stress while maintaining NO bioavailability in TM cells. To allow a better drug delivery, a slow release nanosuspension SA-9 nanoparticles (SA-9 NPs) was prepared, characterized, and tested in dexamethasone induced ocular hypertensive (OHT) mice model for IOP lowering activity. A single topical eye drop of SA-9 NPs significantly lowered IOP (61%) at 3 h post-dose, with the effect lasting up to 72 h. This class of molecule has high potential to be useful for treatment of glaucoma.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Multidisciplinary

Glutathione-responsive biodegradable polyurethane nanoparticles for lung cancer treatment

Roshni Iyer, Tam Nguyen, Dona Padanilam, Cancan Xu, Debabrata Saha, Kytai T. Nguyen, Yi Hong

JOURNAL OF CONTROLLED RELEASE (2020)

Article Biotechnology & Applied Microbiology

Melanoma Peptide MHC Specific TCR Expressing T-Cell Membrane Camouflaged PLGA Nanoparticles for Treatment of Melanoma Skin Cancer

Serkan Yaman, Harish Ramachandramoorthy, Gizem Oter, Daria Zhukova, Tam Nguyen, Manoj K. Sabnani, Jon A. Weidanz, Kytai T. Nguyen

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)

Article Nanoscience & Nanotechnology

Nano encapsulated novel compound SA-10 with therapeutic activity in both acute and chronic murine hindlimb ischemia models

Louis Hinkle, Duong Le, Tam Nguyen, T. Vy, Charles E. Amankwa, Courtney Weston, Haifa Shen, Kytai T. Nguyen, Maham Rahimi, Suchismita Acharya

Summary: The hybrid molecule SA-10 with dual functions of NO donation and ROS scavenging showed potent cytoprotective effects and tube formation activity in endothelial cells under oxidative stress. SA-10 NPs delivered intramuscularly to murine ischemia models significantly reduced muscle damage and inflammation in acute ischemia/reperfusion, while improving blood perfusion and physical endurance in chronic ischemia model over 30 days. This potential therapeutic alternative to surgery may benefit elderly patients with limited options for interventions.

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2021)

Article Orthopedics

Biomolecule-releasing bioadhesive for glenoid labrum repair through induced host progenitor cell responses

Cynthia M. Co, Tam Nguyen, Bhavya Vaish, Samira Izuagbe, Joseph Borrelli Jr, Liping Tang

Summary: This study evaluated the use of PDGF-releasing adhesives to improve the healing of glenoid labral tears by promoting progenitor cell recruitment and increasing extracellular matrix production. The results showed that PDGF-releasing adhesives significantly enhanced progenitor cell recruitment and labral healing.

JOURNAL OF ORTHOPAEDIC RESEARCH (2023)

Article Cell Biology

Neuroprotection of Rodent and Human Retinal Ganglion Cells In Vitro/Ex Vivo by the Hybrid Small Molecule SA-2

Jennifer H. Pham, Gretchen A. Johnson, Rajiv S. Rangan, Charles E. Amankwa, Suchismita Acharya, Dorota L. Stankowska

Summary: This study evaluated the mechanisms underlying the neuroprotective effects of the compound SA-2 in retinal ganglion cell degeneration models. The results showed that SA-2 reduced apoptosis and decreased reactive oxygen species (ROS) levels in rat and human RGCs, suggesting that it may be a potential therapeutic strategy for preventing neurodegeneration in glaucomatous RGCs.
Article Biochemistry & Molecular Biology

Nanoencapsulated hybrid compound SA-2 with long-lasting intraocular pressure-lowering activity in rodent eyes

Dorota L. Stankowska, J. Cameron Millar, Bindu Kodati, Sumita Behera, Renuka M. Chaphalkar, Tam Nguyen, Kytai T. Nguyen, Raghu R. Krishnamoorthy, Dorette Z. Ellis, Suchismita Acharya

Summary: The new compound SA-2 has been shown to upregulate cGMP in TM cells, increase outflow facility, and decrease IOP in rodent models. It provides cytoprotective activity by scavenging ROS and enhancing SOD enzyme activity. The PLGA nanosuspension formulation (SA-2 NPs) offers a longer duration of IOP-lowering activity compared to the free drug.

MOLECULAR VISION (2021)

Article Materials Science, Biomaterials

Enhanced Endothelial Cell Delivery for Repairing Injured Endothelium via Pretargeting Approach and Bioorthogonal Chemistry

Min Kyung Khang, Aneetta Elizabeth Kuriakose, Tam Nguyen, Cynthia My-Dung Co, Jun Zhou, Thuy Thi Dang Truong, Kytai Truong Nguyen, Liping Tang

ACS BIOMATERIALS SCIENCE & ENGINEERING (2020)

Article Ophthalmology

Hybrid Compound SA-2 is Neuroprotective in Animal Models of Retinal Ganglion Cell Death

Dorota L. Stankowska, Adnan Dibas, Linya Li, Wei Zhang, Vignesh R. Krishnamoorthy, Sai H. Chavala, Tam Pho Nguyen, Thomas Yorio, Dorette Z. Ellis, Suchismita Acharya

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2019)

暂无数据